分子影像学在心力衰竭中的应用及其进展

涂应锋; 卜丽红; 黄涛; 申宝忠

doi:10.13201/j.issn.1001-1439.2012.07.008

分子影像学在心力衰竭中的应用及其进展

- 哈尔滨医科大学分子影像中心(哈尔滨, 150001)

详细信息

通讯作者: 申宝忠,E-mail:shbzlabvip@sina.com

中图分类号: R541.6

收稿日期: 2011-10-17

修回日期: 2012-01-16

Progress of molecular imaging in heart failure

- Molecular Imaging Center, Harbin Medical College, Harbin, 150001, China

More Information

Corresponding author: SHEN Baozhong, E-mail: shbzlabvip@sina.com

Received Date: 17 October 2011

Revised Date: 16 January 2012

摘要

摘要: 心力衰竭是一种复杂的临床症候群,是各种心脏病的终末阶段。其发病率高,5年存活率与恶性肿瘤相仿。分子影像学以心力衰竭过程中特异性分子标志物为靶标,应用分子影像学技术平台,能够无创、可重复、实时地获得体内的动态、定量和可视化的心力衰竭的发生发展过程。本文综述了分子影像学在心力衰竭应用中的一些最新进展。
- 心力衰竭 /
- 分子影像学
Abstract: Heart failure is a complex clinical syndrome,which is the final stage of all kinds of heart disease.The 5years survival rate of patient with heart failure is similar to malignant tumor.Molecular imaging could localize myocardial biomarkers in patient of heart failure high sensitivity,and detect the dynamic,quantitative and visualization process.In this article,the applications of molecular imaging in heart failure are reviewed.
- heart failure /
- molecular imaging

HTML全文

参考文献(28)

[1]	KRUM H. The Task Force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure:full text (update 2005)[J]. Eur Heart J,2005,26:2472-2474.
[2]	BLEUMINK G S,KNETSCH A M,STURKENBOOM M C,et al.Quantifying the heart failure epidemic:prev-alence,incidence rate,lifetime risk and prognosis of heart failure The Rotterdam Study[J].Eur Heart J,2004,25:1614-1619.
[3]	WEISSLEDER R. Molecular imaging:exploring the next frontier[J]. Radiology,1999,212:609-614.
[4]	CHERRY S R.Multimodality in vivo imaging sys-tems:twice the power or double the trouble?[J].Annu Rev Biomed Eng,2006,8:35-62.
[5]	SMITH J J,SORENSEN A G,THRALL J H.Bio-markers in imaging:realizing radiology's future[J].Radiology,2003,227:633-638.
[6]	NEGLIA D,MICHELASSI C,TRIVIERI M G,et al.Prognostic role of myocardial blood flow impair-ment in idiopathic left ventricular dysfunction[J].Cir-culation,2002,105:186-193.
[7]	SCHINKEL A F, BAX J J, POLDERMANS D, et al. Hibernating myocardium:diagnosis and patient outcomes[J]. Curr Probl Cardiol,2007,32:375-410.
[8]	KNUUTI J, SCHELBERT H R, BAX J J. The need for standardisation of cardiac FDG PET imaging in the evaluation of myocardial viability in patients with chronic ischaemic left ventricular dysfunction[J]. Eur J Nucl Med Mol Imaging,2002,29:1257-1266.
[9]	KUHL H P,LIPKE C S,KROMBACH G A,et al.Assessment of reversible myocardial dysfunction in chronic ischaemic heart disease:comparison of con-trast-enhanced cardiovascular magnetic resonance and a combined positron emission tomography-single pho-ton emission computed tomography imaging protocol[J].Eur Heart J,2006,27:846-853.
[10]	KIM R J,WU E,RAFAEL A,et al.The use of con-trast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction[J].N Engl J Med,2000,343:1445-1453.
[11]	KNAAPEN P, GERMANS T, KNUUTI J, et al. Myocardial energetics and efficiency:current status of the noninvasive approach[J]. Circulation,2007,115:918-927.
[12]	JACOBSON A F, SENIOR R, CERQUEIRA M D, et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study[J]. J Am Coll Cardiol,2010,55:2212-2221.
[13]	FALLAVOLLITA J A,BANAS M D,SUZUKI G,et al.11C-meta-hydroxyephedrine defects persist de-spite functional improvement in hibernating myocardi-um[J].J Nucl Cardiol,2010,17:85-96.
[14]	NAKATA T,WAKABAYASHI T,KYUMA M,et al.Cardiac metaiodobenzylguanidine activity can pre-dict the long-term efficacy of angiotensin-convertingenzyme inhibitors and/or beta-adrenoceptor blockers in patients with heart failure[J].Eur J Nucl Med Mol Imaging,2005,32:186-194.
[15]	HAUBNER R. Alphavbeta3-integrin imaging:a new approach to characterise angiogenesis?[J]. Eur J Nucl Med Mol Imaging,2006,33(Suppl 1):54-63.
[16]	HUA J,DOBRUCKI L W,SADEGHI M M,et al.Noninvasive imaging of angiogenesis with a99mTc-la-beled peptide targeted at alphavbeta3integrin after murine hindlimb ischemia[J].Circulation,2005,111:3255-3260.
[17]	WINTER P M,MORAWSKI A M,CARUTHERS S D,et al.Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nan-oparticles[J].Circulation,2003,108:2270-2274.
[18]	MEOLI D F,SADEGHI M M,KRASSILNIKOVA S,et al.Noninvasive imaging of myocardial angiogen-esis following experimental myocardial infarction[J].J Clin Invest,2004,113:1684-1691.
[19]	HANNIGAN G E,COLES J G,DEDHAR S.Inte-grin-linked kinase at the heart of cardiac contractility,repair,and disease[J].Circ Res,2007,100:1408-1414.
[20]	KOSTIN S, POOL L, ELSASSER A, et al. Myocytes die by multiple mechanisms in failing human hearts[J]. Circ Res,2003,92:715-724.
[21]	DUMONT E A, REUTELINGSPERGER C P, SMITS J F, et al. Real-time imaging of apoptotic cell-membrane changes at the single-cell level in the beating murine heart[J]. Nat Med,2001,7:1352-1355.
[22]	MURAKAMI Y, TAKAMATSU H, TAKI J, et al. A PET tracer for apoptosis imaging[J]. Eur J Nucl Med Mol Imaging,2004,31:469-474.
[23]	SOSNOVIK D E,SCHELLENBERGER E A,NAHR-ENDORF M,et al.Magnetic resonance imaging of car-diomyocyte apoptosis with a novel magneto-optical nanop-article[J].Magn Reson Med,2005,54:718-724.
[24]	KRAITCHMAN D L,TATSUMI M,GILSON W D,et al.Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction[J].Cir-culation,2005,112:1451-1461.
[25]	BRENNER W,AICHER A,ECKEY T,et al.In-la-beled CD34+hematopoietic progenitor cells in a rat myocardial infarction model[J].J Nucl Med,2004,45:512-518.
[26]	HILL J M,DICK A J,RAMAN V K,et al.Serial cardiac magnetic resonance imaging of injected mesen-chymal stem cells[J].Circulation,2003,108:1009-1014.
[27]	CAO F,LIN S,XIE X,et al.In vivo visualization of embryonic stem cell survival,proliferation,and mi-gration after cardiac delivery[J].Circulation,2006,113:1005-1014.
[28]	RAO V P,MIYAGI N,RICCI D,et al.Sodium io-dide symporter(hNIS)permits molecular imaging of gene transduction in cardiac transplantation[J].Transplantation,2007,84:1662-1666.